Pliva v. Mensing: Generic Consumers' Unfortunate Hand
55 Pages Posted: 1 Oct 2012
Date Written: 2012
The United States Supreme Court held in PLIVA v. Mensing that federal preemption immunizes generic drug manufacturers from liability for state law failure-to-warn claims. As a result, consumers harmed by a mislabeled generic drug will be unable to bring actions against generic manufacturers under state law. The Court confessed that the resulting federal drug-labeling scheme dealt consumers an “unfortunate hand.” By removing generic manufacturers’ duty to improve the adequacy of their products’ warning labels, the Supreme Court calls into question the safety of generic drugs.
Suggested Citation: Suggested Citation
Lee, Stacey B., Pliva v. Mensing: Generic Consumers' Unfortunate Hand (2012). Yake Journal of Health Policy, Law, and Ethics, Vol. XII, No. 209, 2012, Available at SSRN: https://ssrn.com/abstract=2155403
Do you have a job opening that you would like to promote on SSRN?
Feedback to SSRN
If you need immediate assistance, call 877-SSRNHelp (877 777 6435) in the United States, or +1 212 448 2500 outside of the United States, 8:30AM to 6:00PM U.S. Eastern, Monday - Friday.